1,720,961 research outputs found

    Going Beyond Counting First Authors in Author Co-citation Analysis

    Get PDF
    The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed

    Variations on the Author

    Get PDF
    “Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship

    Appropriate Similarity Measures for Author Cocitation Analysis

    Get PDF
    We provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis

    Dispelling the Myths Behind First-author Citation Counts

    Get PDF
    We conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more sophisticated methods

    Author Index

    No full text
    Nao informado

    koamabayili/VECTRON-author-checklist: VECTRON author checklist

    No full text
    We have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used

    Nociceptive behavior in animal models for peripheral neuropathy: Spinal and supraspinal mechanisms

    No full text
    Since the initial description by Wall [Wall, P.D., 1967. The laminar organization of dorsal horn and effects of descending impulses. J. Neurophysiol. 188, 403-423] of tonic descending inhibitory control of dorsal horn neurons, several studies have aimed to characterize the role of various brain centers in the control of nociceptive input to the spinal cord. The role of brainstem centers in pain inhibition has been well documented over the past four decades. Lesion to peripheral nerves results in hypersensitivity to mild tactile or cold stimuli (allodynia) and exaggerated response to nociceptive stimuli (hyperalgesia), both considered as cardinal signs of neuropathic pain. The increased interest in animal models for peripheral neuropathy has raised several questions concerning the rostral conduction of the neuropathic manifestations and the role of supraspinal centers, especially brainstem, in the inhibitory control or in the abnormal contribution to the maintenance and facilitation of neuropathic-like behavior. This review aims to summarize the data on the ascending and descending modulation of neuropathic manifestations and discusses the recent experimental data on the role of supraspinal centers in the control of neuropathic pain. In particular, the review emphasizes the importance of the reciprocal interconnections between the analgesic areas of the brainstem and the pain-related areas of the forebrain. The latter includes the cerebral limbic areas, the prefrontal cortex, the intralaminar thalamus and the hypothalamus and play a critical role in the control of pain considered as part of an integrated behavior related to emotions and various homeostatic regulations. We finally speculate that neuropathic pain, like extrapyramidal motor syndromes, reflects a disorder in the processing of somatosensory information. © 2008 Elsevier Ltd. All rights reserved.Abbadie C, 1996, NEUROSCIENCE, V70, P201, DOI 10.1016-0306-4522(95)00343-H; ABBOTT FV, 1978, EXP NEUROL, V62, P720, DOI 10.1016-0014-4886(78)90280-7; AKIL H, 1976, SCIENCE, V191, P961, DOI 10.1126-science.1251210; AKIL H, 1972, BRAIN RES, V44, P692, DOI 10.1016-0006-8993(72)90338-1; Al Amin HA, 2004, NEUROSCI LETT, V364, P27, DOI 10.1016-j.neulet.2004.04.017; ALBEFESSARD D, 1985, BRAIN RES REV, V9, P217, DOI 10.1016-0165-0173(85)90013-X; Aley KO, 1996, NEUROSCIENCE, V73, P259, DOI 10.1016-0306-4522(96)00020-6; Ali Z, 1999, J NEUROPHYSIOL, V81, P455; ANDERSEN E, 1983, BRAIN RES, V269, P57, DOI 10.1016-0006-8993(83)90962-9; Ansah OB, 2007, EXP NEUROL, V205, P536, DOI 10.1016-j.expneurol.2007.03.010; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016-j.ejpain.2004.11.001; ATTAL N, 1991, PAIN, V47, P65, DOI 10.1016-0304-3959(91)90012-M; Authier N, 2003, EXP NEUROL, V182, P12, DOI 10.1016-S0014-4886(03)00003-7; Azami J, 2001, PAIN, V92, P53, DOI 10.1016-S0304-3959(00)00471-1; Back SK, 2003, NEUROREPORT, V14, P1623, DOI 10.1097-01.wnr.0000086253.76SO4.aa; BACKONJA M, 1994, BRAIN RES, V639, P337, DOI 10.1016-0006-8993(94)91750-7; BACKONJA MM, 1995, NEUROSCI LETT, V196, P61, DOI 10.1016-0304-3940(95)11844-M; Baez MA, 2005, J NEUROSCI, V25, P384, DOI 10.1523-JNEUROSCI.3536-04.2005; Bailey AL, 2006, NEUROSCIENCE, V138, P675, DOI 10.1016-j.neuroscience.2005.11.051; Baliki M, 2003, NEUROSCIENCE, V120, P1093, DOI 10.1016-S0306-4522(03)00408-1; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016-0166-2236(94)90047-7; BANDLER R, 1988, BRAIN RES, V439, P95, DOI 10.1016-0006-8993(88)91465-5; Bao L, 2002, EUR J NEUROSCI, V16, P175, DOI 10.1046-j.1460-9568.2002.02080.x; BARASI S, 1983, J PHYSIOL, V343; BARNES CD, 1979, PAIN, V6, P207, DOI 10.1016-0304-3959(79)90128-3; BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002-ana.410040511; BASBAUM AI, 1978, J COMP NEUROL, V178, P209, DOI 10.1002-cne.901780203; BASBAUM AI, 1976, BRAIN RES, V116, P181, DOI 10.1016-0006-8993(76)90899-4; BASBAUM AI, 1977, PAIN, V3, P43, DOI 10.1016-0304-3959(77)90034-3; BASBAUM AI, 1976, P NATL ACAD SCI USA, V73, P4685, DOI 10.1073-pnas.73.12.4685; BEALL JE, 1976, BRAIN RES, V114, P328, DOI 10.1016-0006-8993(76)90675-2; BEHBEHANI MM, 1994, PAIN, V58, P421, DOI 10.1016-0304-3959(94)90137-6; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016-0304-3959(88)90209-6; BENNETT GJ, 1979, BRAIN RES, V172, P243, DOI 10.1016-0006-8993(79)90536-5; Bennett GJ, 1999, P NATL ACAD SCI USA, V96, P7737, DOI 10.1073-pnas.96.14.7737; BERKLEY KJ, 1995, NAT MED, V1, P766, DOI 10.1038-nm0895-766; BERNARD JF, 1990, J NEUROPHYSIOL, V63, P473; BERNARD JF, 1992, J NEUROPHYSIOL, V68, P551; BERNARD JF, 1989, NEUROSCI LETT, V100, P83, DOI 10.1016-0304-3940(89)90664-2; Berner NJ, 1999, BRAIN RES, V831, P155, DOI 10.1016-S0006-8993(99)01426-2; Besson J M, 1980, Acta Neurochir Suppl (Wien), V30, P201; Besson J M, 1987, Pain Headache, V9, P64; BESSON JMR, 1980, PAIN SOC, P161; BESTER H, 1995, J NEUROPHYSIOL, V73, P568; Bester H, 2000, J COMP NEUROL, V428, P45, DOI 10.1002-1096-9861(20001204)428:145::AID-CNE53.0.CO;2-A; Bian D, 1998, NEUROSCI LETT, V241, P79, DOI 10.1016-S0304-3940(98)00051-2; Birder LA, 1999, J PHYSIOL-LONDON, V515, P533, DOI 10.1111-j.1469-7793.1999.533ac.x; BLAIR RW, 1993, NEUROSCI LETT, V162, P133, DOI 10.1016-0304-3940(93)90578-9; Boivie J, 2006, WALL MELZACKS TXB PA, P1057; Bomholt SF, 2005, BRAIN RES, V1044, P216, DOI 10.1016-j.brainres.2005.03.005; BOWKER RM, 1983, BRAIN RES, V288, P33, DOI 10.1016-0006-8993(83)90079-3; BOWKER RM, 1990, BRAIN RES, V512, P15, DOI 10.1016-0006-8993(90)91164-C; Braz JM, 2005, NEURON, V47, P787, DOI 10.1016-j.neuron.2005.08.015; Bruggemann J, 2001, J PAIN, V2, P220, DOI 10.1054-jpai.2001.22792; Burgess SE, 2002, J NEUROSCI, V22, P5129; BURNSTEIN R, 1993, BRAIN RES, V497, P149; Bushnell MC, 2006, WALL MELZACKS TXB PA, P107; Calcutt NA, 2002, INT REV NEUROBIOL, V50, P205; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016-0304-3959(88)90027-9; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016-j.neuron.2006.09.021; CARSTENS E, 1993, J NEUROPHYSIOL, V70, P621; CARSTENS E, 1983, J NEUROPHYSIOL, V50, P192; Casey KL, 2003, EXP NEUROL, V184, P80, DOI 10.1016-j.expneurol.2003.07.006; Casey KL, 2000, PAIN CLIN UPDATES, VVIII, P1; TASKER RR, 1991, SYMP PAIN R, P31; CASTROLOPES JM, 1995, BRAIN RES, V679, P289, DOI 10.1016-0006-8993(95)00262-O; Catheline G, 1999, PAIN, V80, P347, DOI 10.1016-S0304-3959(98)00234-6; Cervero F, 1996, PAIN, V68, P13, DOI 10.1016-S0304-3959(96)03165-X; Cervero F, 2003, EUR J PAIN, V7, P345, DOI 10.1016-S1090-3801(03)00047-8; CHANDLER MJ, 1991, PAIN, V44, P81, DOI 10.1016-0304-3959(91)90152-N; CHENG ZF, 1986, BRAIN RES, V375, P57, DOI 10.1016-0006-8993(86)90958-3; CHI SI, 1993, BRAIN RES, V617, P225, DOI 10.1016-0006-8993(93)91090-F; CHI SI, 1993, BRAIN RES, V617, P220, DOI 10.1016-0006-8993(93)91089-B; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016-0304-3959(94)00172-B; CLARKE RW, 1994, BRAIN RES, V636, P169, DOI 10.1016-0006-8993(94)90195-3; CLIFFER KD, 1991, J NEUROSCI, V11, P852; Coffeen U, 2008, EUR J PAIN, V12, P535, DOI 10.1016-j.ejpain.2007.08.008; COFFIELD JA, 1992, J COMP NEUROL, V321, P488, DOI 10.1002-cne.903210314; Colburn RW, 1997, J NEUROIMMUNOL, V79, P163, DOI 10.1016-S0165-5728(97)00119-7; Colburn RW, 1999, EXP NEUROL, V157, P289, DOI 10.1006-exnr.1999.7065; COLE JD, 1987, J NEUROL NEUROSUR PS, V50, P1083, DOI 10.1136-jnnp.50.8.1083; CONTI F, 1990, NEUROSCIENCE, V34, P607, DOI 10.1016-0306-4522(90)90168-4; COOPER SJ, 1975, NATURE, V254, P439, DOI 10.1038-254439a0; COURTEIX C, 1993, PAIN, V53, P81, DOI 10.1016-0304-3959(93)90059-X; Cui M, 1999, J PHARMACOL EXP THER, V289, P868; Dafny N, 1996, NEUROSCIENCE, V70, P449, DOI 10.1016-0306-4522(95)00358-4; Danziger N, 2001, PAIN, V91, P287, DOI 10.1016-S0304-3959(00)00451-6; DAVAR G, 1991, BRAIN RES, V553, P327, DOI 10.1016-0006-8993(91)90844-L; Day AS, 2001, BRAIN RES, V895, P194, DOI 10.1016-S0006-8993(01)02095-9; DECINA P, 1992, AM J PSYCHIAT, V149, P1075; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016-S0304-3959(00)00276-1; DeLeo JA, 1996, J INTERF CYTOK RES, V16, P695, DOI 10.1089-jir.1996.16.695; DeLeo JA, 1999, CYTOKINES PAIN, P159; DERBYSHIRE SW, 1999, CURRENT REV PAIN, V3, P265, DOI 10.1007-s11916-999-0044-7; Devor M., 2006, TXB PAIN, P905; DEVOR M, 1978, NATURE, V276, P75, DOI 10.1038-276075a0; Devor M, 2001, PAIN, V94, P101, DOI 10.1016-S0304-3959(01)00345-1; Devor M, 2006, J PAIN, V7, pS3, DOI 10.1016-j.jpain.2005.09.006; DEVOR M, 1990, J NEUROPHYSIOL, V64, P1733; DICKENSON A, 1983, PAIN, V17, P213, DOI 10.1016-0304-3959(83)90094-5; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523-JNEUROSCI.3388-05.2006; Donahue RR, 2001, BRAIN RES, V897, P131, DOI 10.1016-S0006-8993(01)02103-5; DOSTROVSKY JO, 1976, EXP NEUROL, V52, P480, DOI 10.1016-0014-4886(76)90219-3; DOUGHERTY PM, 1994, PROG PAIN RES MANAG, V3, P439; DRAY A, 1993, TRENDS PHARMACOL SCI, V14, P287, DOI 10.1016-0165-6147(93)90041-H; DROWER EJ, 1988, BRAIN RES, V450, P316, DOI 10.1016-0006-8993(88)91570-3; DUBOIS A, 1986, NEUROSCIENCE, V19, P125, DOI 10.1016-0306-4522(86)90010-2; DUBUISSON D, 1980, BRAIN RES, V199, P283, DOI 10.1016-0006-8993(80)90690-3; Duncan GH, 1998, J NEUROPHYSIOL, V80, P3326; El-Khoury C, 2002, NEUROSCIENCE, V112, P541, DOI 10.1016-S0306-4522(02)00111-2; Fang F, 1996, BRAIN RES, V722, P95, DOI 10.1016-0006-8993(96)00198-9; Fang F, 1998, BRAIN RES, V790, P14, DOI 10.1016-S0006-8993(97)01441-8; FARDIN V, 1984, Brain Research, V306, P105, DOI 10.1016-0006-8993(84)90360-3; FARDIN V, 1984, Brain Research, V306, P125, DOI 10.1016-0006-8993(84)90361-5; Fecho K, 2006, J NEUROENDOCRINOL, V18, P504, DOI 10.1111-j.1365-2826.2006.01442.x; Fields H, 2006, TXB PAIN, P125; FIELDS HL, 1983, J NEUROSCI, V3, P2545; FIELDS HL, 1978, PAIN, V5, P333, DOI 10.1016-0304-3959(78)90002-7; FIELDS HL, 1995, J NEUROPHYSIOL, V74, P1742; FIELDS HL, 1978, ANNU REV PHYSIOL, V40, P217, DOI 10.1146-annurev.ph.40.030178.001245; FIORI MG, 1995, TOXICOL PATHOL, V23, P248; Floyd NS, 2000, J COMP NEUROL, V422, P556, DOI 10.1002-1096-9861(20000710)422:4556::AID-CNE63.0.CO;2-U; FOONG FW, 1986, PAIN, V27, P361, DOI 10.1016-0304-3959(86)90160-0; Fukuoka T, 1998, PAIN, V78, P13, DOI 10.1016-S0304-3959(98)00111-0; Gao K, 2001, BRAIN RES, V900, P306, DOI 10.1016-S0006-8993(01)02294-6; Gao KM, 1997, J NEUROSCI, V17, P3285; Gao KM, 2000, J NEUROPHYSIOL, V84, P1719; Gao X, 2001, BRAIN RES BULL, V54, P391, DOI 10.1016-S0361-9230(00)00460-3; Gao YJ, 2004, PAIN, V110, P343, DOI 10.1016-j.pain.2004.04.030; Garcia-Larrea L, 2007, NEUROIMAGE, V37, pS71, DOI 10.1016-j.neuroimage.2007.05.062; Garcia-Nicas E, 2006, J NEUROPHYSIOL, V96, P661, DOI 10.1152-jn.00377.2006; Gardell LR, 2004, NEUROSCIENCE, V123, P43, DOI 10.1016-j.neuroscience.2003.08.021; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113-eph8702357; Gauriau C, 2004, J COMP NEUROL, V468, P24, DOI 10.1002-cne.10873; Gear RW, 1999, J NEUROSCI, V19, P7175; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016-j.neubiorev.2003.11.008; GEBHART GF, 1986, J NEUROSCI, V6, P701; GERHART KD, 1983, J NEUROPHYSIOL, V49, P406; GIESLER GJ, 1994, TRENDS NEUROSCI, V17, P244, DOI 10.1016-0166-2236(94)90007-8; Godinho F, 2006, J NEUROSCI, V26, P11454, DOI 10.1523-JNEUROSCI.2260-06.2006; Goettl VM, 2002, PAIN, V99, P359, DOI 10.1016-S0304-3959(02)00209-9; Goff JR, 1998, NEUROSCIENCE, V82, P559; Goffaux P, 2007, PAIN, V130, P137, DOI 10.1016-j.pain.2006.11.011; Goncalves L, 2007, EUR J NEUROSCI, V26, P2188, DOI 10.1111-j.1460-9568.2007.05832.x; GRACELY RH, 1992, PAIN, V51, P175, DOI 10.1016-0304-3959(92)90259-E; GRANATA AR, 1994, BRAIN RES, V648, P299, DOI 10.1016-0006-8993(94)91131-2; GRANTHAM EG, 2001, J NEUROSURG, V8, P405; GUILBAUD G, 1990, J NEUROPHYSIOL, V64, P1537; GUILBAUD G, 1994, PROG PAIN RES MANAG, V3, P339; HABER LH, 1979, ADV PAIN RES THER, V3, P861; HABER LH, 1980, J NEUROPHYSIOL, V43, P1578; HAGBARTH KE, 1954, J NEUROPHYSIOL, V17, P295; Hamani C, 2006, PAIN, V125, P188, DOI 10.1016-j.pain.2006.05.019; HARDY SGP, 1985, BRAIN RES, V339, P281; HARDY SGP, 1985, BRAIN RES, V339, P285; Hashizume H, 2000, SPINE, V25, P1206, DOI 10.1097-00007632-200005150-00003; HAYES RL, 1984, BRAIN RES, V311, P267, DOI 10.1016-0006-8993(84)90089-1; HAYES RL, 1979, BRAIN RES, V167, P417, DOI 10.1016-0006-8993(79)90838-2; Hefferan MP, 2003, PAIN, V101, P139, DOI 10.1016-S0304-3959(02)00322-6; HEINRICHER MM, 1989, SOMATOSENS MOT RES, V6, P427; Heinricher MM, 2003, PROG PAIN RES MANAG, V24, P251; Heinricher MM, 2001, J NEUROPHYSIOL, V85, P280; Hellman KM, 2007, J NEUROPHYSIOL, V98, P3121, DOI 10.1152-jn.00904.2007; HERBERT H, 1990, J COMP NEUROL, V293, P540, DOI 10.1002-cne.902930404; HIRATO M, 1994, STEREOT FUNCT NEUROS, V62, P300, DOI 10.1159-000098636; HODGE CJ, 1981, BRAIN RES, V204, P415, DOI 10.1016-0006-8993(81)90600-4; Hokfelt T., 2006, WALL MELZACKS TXB PA, P947; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016-S0306-4522(00)00110-X; HOSOBUCH.Y, 1973, ARCH NEUROL-CHICAGO, V29, P158; HOSOBUCHI Y, 1977, SCIENCE, V197, P183, DOI 10.1126-science.301658; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016-S0306-4522(02)00065-9; Hughes DI, 2003, J NEUROSCI, V23, P9491; IADAROLA MJ, 1995, PAIN, V63, P55, DOI 10.1016-0304-3959(95)00015-K; Ibuki T, 1997, NEUROSCIENCE, V76, P845; Ikeda R, 2007, PAIN, V127, P161, DOI 10.1016-j.pain.2006.09.003; Jabbur SJ, 1998, PAIN MECHANISMS AND MANAGEMENT, P164; JABBUR SJ, 1999, PAIN S, V6, P87; Jabbur SJ, 2000, PAIN AND NEUROIMMUNE INTERACTIONS, P223; JACOBS BL, 1991, PHARMACOL REV, V43, P563; Jacobs BL, 2002, BRAIN RES REV, V40, P45, DOI 10.1016-S0165-0173(02)00187-X; JACOBS BL, 1992, PHYSIOL REV, V72, P165; Jasmin L, 2003, NATURE, V424, P316, DOI 10.1038-nature01808; Jasmin L, 2003, J COMP NEUROL, V460, P38, DOI 10.1002-cne.10633; Jasmin L, 2004, J COMP NEUROL, V468, P425, DOI 10.1002-cne.10978; Jeanmonod D, 1996, BRAIN, V119, P363, DOI 10.1093-brain-119.2.363; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073-pnas.141218998; KAJANDER KC, 1990, PEPTIDES, V11, P719, DOI 10.1016-0196-9781(90)90187-A; KAPLAN H, 1991, J NEUROSCI, V11, P1433; KATAYAMA Y, 1985, APPL NEUROPHYSIOL, V48, P195; Kauppila T, 1998, PAIN, V74, P55, DOI 10.1016-S0304-3959(97)00143-7; Kauppila T, 1998, BRAIN RES, V797, P234, DOI 10.1016-S0006-8993(98)00379-5; Kawamata M, 1996, PAIN, V68, P85, DOI 10.1016-S0304-3959(96)03222-8; KAYSER V, 1994, PROG PAIN RES MANAG, V2, P553; Kerman IA, 2006, J COMP NEUROL, V499, P882, DOI 10.1002-cne.21129; Khasabov SG, 2002, J NEUROSCI, V22, P9086; Khasabov SG, 1999, BRIT J PHARMACOL, V127, P843, DOI 10.1038-sj.bjp.0702592; Khasabov SG, 2005, J NEUROPHYSIOL, V93, P998, DOI 10.1152-jn.01160.2003; KIM SH, 1992, PAIN, V50, P355; KINNMAN E, 1995, NEUROSCIENCE, V64, P751, DOI 10.1016-0306-4522(94)00435-8; KIRK EJ, 1970, J COMP NEUROL, V139, P307, DOI 10.1002-cne.901390304; KIRK EJ, 1974, J COMP NEUROL, V155, P165, DOI 10.1002-cne.901550203; Kolesnikov Y, 2007, EUR J PHARMACOL, V568, P124, DOI 10.1016-j.ejphar.2007.04.045; Kontinen VK, 2003, PROG PAIN RES MANAG, V24, P489; Kovelowski CJ, 2000, PAIN, V87, P265, DOI 10.1016-S0304-3959(00)00290-6; Kumar K, 1997, NEUROSURGERY, V40, P736, DOI 10.1097-00006123-199704000-00015; KUPERS RC, 1993, NEUROSCI LETT, V150, P95, DOI 10.1016-0304-3940(93)90116-3; KUPERS RC, 1988, PAIN, V32, P115, DOI 10.1016-0304-3959(88)90030-9; LaBuda CJ, 2005, NEUROSCIENCE, V136, P311, DOI 10.1016-j.neuroscience.2005.07.010; LaBuda CJ, 2000, NEUROSCI LETT, V290, P79, DOI 10.1016-S0304-3940(00)01323-9; LaGraize SC, 2004, EXP NEUROL, V188, P139, DOI 10.1016-j.expneurol.2004.04.003; Lai J, 2001, Mol Interv, V1, P160; LAIRD JMA, 1993, J NEUROPHYSIOL, V69, P2072; Le Bars D, 2002, BRAIN RES REV, V40, P29, DOI 10.1016-S0165-0173(02)00186-8; LEBARS D, 2001, PHARMACOL REV, V53, DOI UNSP 597652; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lee BH, 2000, NEUROSCI LETT, V291, P29, DOI 10.1016-S0304-3940(00)01375-6; Lee MA, 2006, J PAIN SYMPTOM MANAG, V32, P462, DOI 10.1016-j.jpainsymman.2006.05.020; LENZ FA, 1989, BRAIN RES, V496, P357, DOI 10.1016-0006-8993(89)91088-3; Lenz FA, 1997, THALAMUS EXPT CLIN A, VII, P617; Lenz FA, 1997, PAIN FORUM, V6, P22; Leung CG, 1998, J NEUROPHYSIOL, V80, P1630; LEWIS VA, 1977, BRAIN RES, V124, P283, DOI 10.1016-0006-8993(77)90886-1; Li L, 2002, EXP NEUROL, V175, P23, DOI 10.1006-exnr.2002.7897; Li L, 2003, MOL CELL NEUROSCI, V23, P232, DOI 10.1016-S1044-7431(03)00062-9; LIEBESKI.JC, 1973, BRAIN RES, V50, P441, DOI 10.1016-0006-8993(73)90748-8; Lima D, 2002, PROG NEUROBIOL, V66, P81, DOI 10.1016-S0301-0082(01)00025-9; LINDEROTH B, 2001, NEUROPATHIC PAIN PAT, P223; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016-S0304-3959(00)00251-7; Lopes P, 1997, NEUROSCIENCE, V78, P481, DOI 10.1016-S0306-4522(96)00554-4; Lopez-Avila A, 2004, PAIN, V111, P136, DOI 10.1016-j.pain.2004.06.010; LU X, 1993, J NEUROCYTOL, V22, P334, DOI 10.1007-BF01195557; LUUKKO M, 1993, EXP NEUROL, V124, P390, DOI 10.1006-exnr.1993.1212; Ma C, 2003, J NEUROPHYSIOL, V89, P1588, DOI 10.1152-jn.00855.2002; Ma QP, 2001, BRAIN RES, V904, P137, DOI 10.1016-S0006-8993(01)02420-9; Ma W, 1998, NEUROSCIENCE, V86, P1217, DOI 10.1016-S0306-4522(98)00068-2; Ma WY, 2003, BRAIN RES, V970, P110, DOI 10.1016-S0006-8993(03)02293-5; Magnin M, 2005, NEUROPHYSIOL CLIN, V35, P154, DOI 10.1016-j.neucli.2005.12.002; Malan TP, 2000, PAIN, V86, P185, DOI 10.1016-S0304-3959(00)00243-8; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097-00000542-200205000-00020; Malcangio M, 2000, EUR J NEUROSCI, V12, P397, DOI 10.1046-j.1460-9568.2000.00946.x; Malick A, 2000, J NEUROPHYSIOL, V84, P2078; MAO J, 1992, BRAIN RES, V576, P254, DOI 10.1016-0006-8993(92)90688-6; MAO JR, 1995, PAIN, V62, P259, DOI 10.1016-0304-3959(95)00073-2; MAO JR, 1993, J NEUROSCI, V13, P2689; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038-nrn1700; MARTIN G, 1991, NEUROREPORT, V2, P509, DOI 10.1097-00001756-199109000-00003; Mason P, 2005, J COMP NEUROL, V493, P2, DOI 10.1002-cne.20751; Mason P, 2007, J NEUROPHYSIOL, V98, P1919, DOI 10.1152-jn.00813.2007; Mason P, 2005, J NEUROPHYSIOL, V94, P1659, DOI 10.1152-jn.00249.2005; Mason P, 2001, ANNU REV NEUROSCI, V24, P737, DOI 10.1146-annurev.neuro.24.1.737; Mason P, 1998, PAIN FORUM, V7, P143; Mason P, 1999, CURR OPIN NEUROBIOL, V9, P436, DOI 10.1016-S0959-4388(99)80065-8; MAYER DJ, 1974, BRAIN RES, V68, P73, DOI 10.1016-0006-8993(74)90534-4; MAYER DJ, 1976, PAIN, V2, P379, DOI 10.1016-0304-3959(76)90080-4; MAYER DJ, 1971, SCIENCE, V174, P1351, DOI 10.1126-science.174.4016.1351; Mazars G J, 1975, Surg Neurol, V4, P93; MCMAHON SB, 1984, PAIN, V19, P235, DOI 10.1016-0304-3959(84)90002-2; MCMAHON SB, 1991, J COMP NEUROL, V304, P307, DOI 10.1002-cne.903040211; MCMAHON SB, 1988, J NEUROPHYSIOL, V59, P1204; MEDORI R, 1988, J NEUROSCI, V8, P1814; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126-science.150.3699.971; MEN DS, 1994, BRAIN RES BULL, V33, P625, DOI 10.1016-0361-9230(94)90225-9; MEN DS, 1994, BRAIN RES BULL, V34, P177; Meyerson Björn A, 2006, J Pain Symptom Manage, V31, pS6, DOI 10.1016-j.jpainsymman.2005.12.009; Miao FJP, 2001, J PHYSIOL-LONDON, V532, P811; Mika J, 2007, EUR J PHARMACOL, V560, P142, DOI 10.1016-j.ejphar.2007.01.013; Miki K, 2000, PAIN, V85, P263, DOI 10.1016-S0304-3959(99)00279-1; Miki K, 1998, PAIN, V76, P407, DOI 10.1016-S0304-3959(98)00073-6; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016-S0301-0082(02)00009-6; MILLAR J, 1976, EXP NEUROL, V50, P658, DOI 10.1016-0014-4886(76)90035-2; Millecamps M, 2007, PAIN, V132, P108, DOI 10.1016-j.pain.2007.03.003; MOGA MM, 1990, J COMP NEUROL, V295, P624, DOI 10.1002-cne.902950408; Molander C, 1997, BRAIN RES, V747, P122, DOI 10.1016-S0006-8993(96)01230-9; Monconduit L, 2006, J NEUROSCI, V26, P8441, DOI 10.1523-JNEUROSCI.1293-06.2006; Monhemius R, 2001, NEUROSCI LETT, V298, P70, DOI 10.1016-S0304-3940(00)01627-X; MONTAGNECLAVEL J, 1995, NEUROSCI LETT, V196, P69, DOI 10.1016-0304-3940(95)11847-P; MONTAGNECLAVEL J, 1994, BRAIN RES, V657, P92, DOI 10.1016-0006-8993(94)90957-1; MONTAGNECLAVEL J, 1995, PAIN, V60, P303, DOI 10.1016-0304-3959(94)00129-3; Moore KA, 2002, J NEUROSCI, V22, P6724; MORGAN MJ, 1988, PAIN, V33, P109, DOI 10.1016-0304-3959(88)90210-2; Morgan MM, 1998, BRAIN RES, V804, P159, DOI 10.1016-S0006-8993(98)00669-6; Morgan MM, 2000, BRAIN RES, V872, P276, DOI 10.1016-S0006-8993(00)02502-6; MORGAN MM, 1989, BRAIN RES, V486, P175, DOI 10.1016-0006-8993(89)91291-2; MORGAN MM, 1994, J NEUROPHYSIOL, V72, P1161; Morin N, 2007, J NEUROIMMUNOL, V184, P164, DOI 10.1016-j.jneuroim.2006.12.009; Narita M, 2006, NEUROPSYCHOPHARMACOL, V31, P739, DOI 10.1038-sj.npp.1300858; Nashold B S, 1975, Surg Neurol, V4, P146; Nason MW, 2004, J NEUROPHYSIOL, V92, P510, DOI 10.1152-jn.00089.2004; Nason MW, 2006, J NEUROSCI, V26, P1190, DOI 10.1523-JNEUROSCI.4707-05.2006; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177-1073858403261077; Neugebauer V, 2007, PAIN, V127, P1, DOI 10.1016-j.pain.2006.10.004; Newman HM, 1996, J COMP NEUROL, V365, P640, DOI 10.1002-(SICI)1096-9861(19960219)365:4640::AID-CNE103.0.CO;2-L; NOGUCHI K, 2006, P 11 WORLD C PAIN, P93; NOGUCHI K, 1995, J NEUROSCI, V15, P7633; Obata K, 2003, PAIN, V101, P65, DOI 10.1016-S0304-3959(02)00296-8; Ohara PT, 2005, CELL MOL LIFE SCI, V62, P44, DOI 10.1007-s00018-004-4283-9; Ohara PT, 2003, J NEUROCYTOL, V32, P131, DOI 10.1023-B:NEUR.0000005598.09647.7f; OLIVERAS JL, 1991, BRAIN RES, V563, P251, DOI 10.1016-0006-8993(91)91541-8; OLIVERAS JL, 1989, BRAIN RES, V486, P1, DOI 10.1016-0006-8993(89)91271-7; OLIVERAS JL, 1975, PAIN, V1, P139, DOI 10.1016-0304-3959(75)90098-6; OLIVERAS JL, 1974, EXP BRAIN RES, V20, P32; OLIVERAS JL, 1977, BRAIN RES, V120, P221, DOI 10.1016-0006-8993(77)90902-7; OLIVERAS JL, 1990, BRAIN RES, V506, P19, DOI 10.1016-0006-8993(90)91194-L; OLIVERAS JL, 1979, BRAIN RES, V164, P317, DOI 10.1016-0006-8993(79)90029-5; OLIVERAS JL, 1991, BRAIN RES, V563, P241, DOI 10.1016-00

    Author Under Sail The Imagination of Jack London, 1893-1902

    No full text
    In Author Under Sail, Jay Williams offers the first complete literary biography of Jack London as a professional writer engaged in the labor of writing. It examines the authorial imagination in London's work, the use of imagination in both his fiction and nonfiction, and the ways he defined imagination in the creative process in his business dealings with his publishers, editors, and agents. In this first volume of a two-volume biography, Williams traverses the years 1893 to 1902, from London's "Story of a Typhoon" to The People of the Abyss. The Jack London who emerges in the pages of Author Under Sail is a writer whose partnership with publishers, most notably his productive alliance with George Brett of Macmillan, was one of the most formative in American literary history. London pioneered many author models during the heyday of realism and naturalism, blurring the boundaries of these popular genres by focusing on absorption and theatricality and the representation of the seen and unseen. London created an impassioned, sincere, and extremely personal realism unlike that of other American writers of the time. Author Under Sail is a literary tour de force that reveals the full range of London as writer, creative citizen, and entrepreneur at the same time it sheds light on the maverick side of machine-age literature.Intro -- Title Page -- Copyright Page -- Dedication -- Contents -- Acknowledgments -- Introduction -- 1. Spirit Truth -- 2. From Absorption to Theatricality and Back Again -- 3. "I Will Build a New Present" -- 4. Sons as Authors -- 5. Fathers as Publishers -- 6. The Daughter as Author -- 7. Lovers as Authors -- 8. At Sea with the Family -- 9. Yellow News, Yellow Stories -- 10. The Return Home -- Notes -- Bibliography -- Index -- About Jay WilliamsIn Author Under Sail, Jay Williams offers the first complete literary biography of Jack London as a professional writer engaged in the labor of writing. It examines the authorial imagination in London's work, the use of imagination in both his fiction and nonfiction, and the ways he defined imagination in the creative process in his business dealings with his publishers, editors, and agents. In this first volume of a two-volume biography, Williams traverses the years 1893 to 1902, from London's "Story of a Typhoon" to The People of the Abyss. The Jack London who emerges in the pages of Author Under Sail is a writer whose partnership with publishers, most notably his productive alliance with George Brett of Macmillan, was one of the most formative in American literary history. London pioneered many author models during the heyday of realism and naturalism, blurring the boundaries of these popular genres by focusing on absorption and theatricality and the representation of the seen and unseen. London created an impassioned, sincere, and extremely personal realism unlike that of other American writers of the time. Author Under Sail is a literary tour de force that reveals the full range of London as writer, creative citizen, and entrepreneur at the same time it sheds light on the maverick side of machine-age literature.Description based on publisher supplied metadata and other sources.Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, YYYY. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries
    corecore